Intimation of Schedule of Analyst / Institutional Investor Meetings
Piramal Enterprises Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".15-11-2016
15-11-2016
Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
Swati Piramal Trust has submitted the disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 201111-11-2016
Intimation of Schedule of Analyst / Institutional Investor Meetings
Piramal Enterprises Ltd has informed BSE regarding "Intimation of Schedule of Analyst / Institutional Investor Meetings".04-11-2016
Payment of Interest
Piramal Enterprises Ltd has informed BSE regarding "Payment of Interest".02-11-2016
OTC to grow as people have no time for doctors: Nandini Piramal
Nandini Piramal (36), daughter of billionaire Ajay Piramal, loves building brands. She is also working to enhance the quality of people at Piramal Enterprises. As executive director, she handles...31-10-2016
Announces Q2 results (Standalone & Consolidated), Limited Review Report (Standalone & Consolidated), Results Press Release & Results Presentation for the Quarter ended September 30, 2016
Piramal Enterprises Ltd has announced the following results for the quarter ended September 30, 2016:The Unaudited Standalone results for the Quarter ended September 30, 2016The Company has posted a net profit of Rs. 4475.80 million for the quarter ended September 30, 2016 as compared to Rs. 2908.10 million for the quarter ended September 30, 2015. Total Income has increased from Rs. 9343.10 million for the quarter ended September...27-10-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Piramal Enterprises Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.21-10-2016
Shareholding for the Period Ended September 30, 2016
Piramal Enterprises Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click here20-10-2016
Q2 results on Oct 27, 2016
Piramal Enterprises Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on October 27, 2016, to consider and approve the Unaudited Financial Results (Consolidated and Standalone) of the Company for the Quarter and Half year ended September 30, 2016 (Q2).In this regard, the Trading Window for dealing in the securities of the Company will remain closed from October 21, 2016 to October 29, 2016 (both days...20-10-2016
Piramal Enterprises buys Janssen's five injectable products for $ 175 mn
The acquisition of anaesthesia and pain management products will enable PEL's critical care division to tap the global generic injectable hospital drug market, which is estimated at about $ 20 bn12-10-2016